montrealgazette.com
Bausch Health posts US$873-billion Q2 loss linked to tax cost, asset impairments
MONTREAL — Bausch Health Companies Inc. posted a net loss of US$873 million in the second quarter as the company formerly known as Valeant Pharmaceuticals experienced a bigger operating loss …